Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xirui Bio (Guangzhou Xirui Bioengineering Co., Ltd.) is a synthetic biology and high-throughput screening company based in Guangzhou, China. The company leverages a proprietary droplet microfluidic platform to accelerate the discovery and optimization of enzymes, microbial strains, and antibodies. Their technology enables the screening of millions of variants per day at the single-cell level, significantly reducing the time and cost associated with traditional protein engineering and strain development. Xirui Bio serves a diverse range of industries, including biopharmaceuticals, industrial chemicals, and agriculture, by providing high-efficiency solutions for biological catalyst optimization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on XIRUI Bioengineering.